A Big Step Forward in Hepatitis C Screening
Nikhil Kapila, Andrew J. Muir – 7 May 2020
Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines
Anthony Myint, Myron J. Tong, Simon W. Beaven – 7 May 2020
Isolated Elevated Bilirubin
Hersh Shroff, Haripriya Maddur – 7 May 2020
A Big Step Forward in Hepatitis C Screening
Nikhil Kapila, Andrew J. Muir – 7 May 2020
Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Ann Robinson, Robert J. Wong – 7 May 2020
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
Francesco Violi, Annarita Vestri, Danilo Menichelli, Arianna Di Rocco, Daniele Pastori, Pasquale Pignatelli – 7 May 2020 – Direct oral anticoagulants (DOACs) have had a positive impact in preventing cardioembolic stroke in patients with atrial fibrillation (AF) who were associated with lower bleeding complications; however, data on subjects with concomitant advanced liver diseases (ALDs) are poor. This meta‐analysis evaluates bleeding and thromboembolic complications in patients with coexisting AF and ALD who were treated with DOACs or vitamin K antagonists (VKAs).
TMEM9‐v‐ATPase Activates Wnt/β‐Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis
Youn‐Sang Jung, Sabrina A. Stratton, Sung Ho Lee, Moon‐Jong Kim, Sohee Jun, Jie Zhang, Biyun Zheng, Christopher L. Cervantes, Jong‐Ho Cha, Michelle C. Barton, Jae‐Il Park – 7 May 2020
Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention
Evelyn F. Miller – 7 May 2020